Microenvironment drives cell state, plasticity, and drug response in pancreatic cancerSrivatsan Raghavan, Alex K. Shalek, Peter Winter et al.|Cell|2021Cited by 586
Comparative analysis of metazoan chromatin organizationJoshua W. K. Ho, Richard Park, Youngsook L. Jung et al.|Nature|2014Cited by 449
Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression LevelsBiagio Ricciuti, Mark M. Awad, Xinan Wang et al.|JAMA Oncology|2022Cited by 383
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Timothy J. Haggerty et al.|Cancer Immunology Research|2022Cited by 88
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic CancerHarshabad Singh, Andrew J. Aguirre, Rachel B. Keller et al.|Clinical Cancer Research|2023Cited by 46